Description
Cenupatide (UPARANT) is a Urokinase-type plasminogen activator receptor (uPAR) inhibitor. Cenupatide has anti-angiogenic and anti-inflammatory efficacy[1].—–C28H47N11O5—-[1]Filippo Locri, et al. UPARANT is an effective antiangiogenic agent in a mouse model of rubeosis iridis. J Mol Med (Berl). 2019, 97, 9.|[2]Cai Yuan, et al. Development of inhibitors for uPAR: blocking the interaction of uPAR with its partners. Drug Discov Today. 2021, 26, 4. –1006388-38-0–617.74—-N=C(N)NCCC[C@H](NC(C)=O)C(NC(C)(C)C(N[C@@H](CCCNC(N)=N)C(N[C@@](C(N)=O)(C)CC1=CC=CC=C1)=O)=O)=O–Cancer–10 mM in DMSO–Others—-Others–Peptides
Did you check our products for animal nutrition?